Turnover at the company rose to 26.3 billion kronor, up from 25.3 billion kronor in the first nine months of last year.
“Self-care and service sales are contributing positively to Apoteket’s results, whereas income from handling prescription drugs is not covering costs,” the company’s interim report said.
Apoteket has a monopoly position on the Swedish market for the sale of prescription and over-the-counter medication. It also sells a wide range of own-brand and branded cosmetics and consumer healthcare products.